tion of the fat-soluble vitamins A, D, E and K. With the use of pancreatic enzyme replacement therapy and routine vitamin supplementation, clinical problems arising from deficiencies of the fat-soluble vitamins became uncommon in children with CF. However, CF patients are still at risk from vitamin deficiency if the diagnosis is made late (Brooks et al. 1990) , if part of the small bowel has been resected (Bye et al. 1985) or if fat-soluble vitamin supplements are not taken (O'Donnell & Talbot, 1987) . In addition, it has been recognized that factors other than simple malabsorption of fat may be important. For example, patients with CF have low circulating levels of retinol-binding protein, which is essential for the transport of retinol from the liver to the tissues (Rees Smith et al. 1972) . Some patients may have low serum levels of retinol and retinolbinding protein despite raised liver concentrations of retinol, suggesting that its release from liver stores is impaired . Reduced enterohepatic circulation of bile acids may also contribute to malabsorption of fat-soluble vitamins from the small bowel (Weber & Roy, 1985) . In addition, patients with liver function abnormalities may have inadequate 25-hydroxylation of vitamin D (Friedman et al. 1985) .
The fat-soluble vitamin status of thirty-six infants consecutively identified by screening in Denver, Colorado was reported recently (Sokol et al. 1989) . At a mean age of 51 (SE 26.7) d, 21% had low serum levels of retinol, 35% low 25-hydroxycholecalciferol levels and 38% low a-tocopherol levels and low total serum vitamin E:total lipids ratios. After treatment with pancreatic enzymes and vitamin supplements, all patients had normal serum levels of retinol and 25-hydroxycholecalciferol by 6 months of age but 10% remained vitamin E deficient. None of the infants had evidence of vitamin K deficiency.
The vitamin status of thirty-six older patients in Leeds was investigated in 1981 in order to assess the adequacy of conventional vitamin supplementation and the effect of short-term supplementation with water-miscible forms of vitamin A and E (Congden et al. 1981) . At that time patients were not receiving vitamin E supplements and serum vitamin E levels were low in 90% of patients and inversely correlated with the severity of the steatorrhoea, but responded well to treatment with 50 mg water-miscible vitamin E daily for 2 weeks. Despite receiving 1.2 mg oil-based vitamin A supplements daily, 40% of patients had low serum retinol levels and these correlated with the retinol-binding protein levels. Serum levels of retinol responded well to 2 weeks of treatment with 1.2 mg water-miscible vitamin A daily. Seven of twenty (35%) patients receiving vitamin D supplements (10 pg daily) had serum levels lower than 15 ng/ml and two (10%) had levels below the normal range. Unfortunately, water-miscible preparations of vitamin A and vitamin E are not readily available on prescription in the UK and tend to be rather 
VITAMIN K
In the newborn, it is important to be aware of the possibility of vitamin K deficiency as a complication of CF, presenting as haemorrhagic disease (Torstenson et al. 1970) , (Walters & Koch, 1972) . Most maternity units now administer prophylactic vitamin K 1 mg orally to all newborn babies, but babies with respiratory problems and those with meconium ileus should receive vitamin K intramuscularly on admission to the neonatal unit (McNinch et al. 1985) . Babies with prolonged neonatal jaundice are particularly at risk and the prothrombin time should be monitored regularly in any CF patient with significant liver disease (Corrigan et al. 1981) . Older children with CF have normal plasma levels of vitamin KI and routine supplementation with vitamin K is not considered necessary (Choonara et al. 1989) .
VITAMIN D
It is perhaps surprising that rickets has been described so rarely in CF (Scott et al. 1977) . This may be due to the fact that dermal synthesis of vitamin D accounts for more than 80% of normal requirements. It has been shown that serum levels of 25-hydroxycholecalciferol vary as would be expected with latitude and seasonal variations in sunlight exposure (Reiter et al. 1985; Thompson, 1987) . However, most studies involving adolescents and adults with CF have shown that serum levels of 25-hydroxycholecalciferol are low compared with age-matched controls and that some patients have evidence of secondary hyperparathyroidism (Hahn el al. 1979; Stead et al. 1988) . Measurements of bone mineralization have been made using photon absorptiometry and have shown a significant reduction in bone mineral index compared with age-matched controls. Adolescent girls appear to be most at risk (Mischler et al. 1979) . Symptomatic osteomalacia has been described in a 25-year-old male patient with previously undiagnosed CF and cirrhosis (Friedman et al. 1985) , but has not been described in adults with CF who have been receiving vitamin D supplementation.
VITAMIN E Neurological problems due to long-standing vitamin E deficiency in patients with CF have been recognized mainly in CF adults during the last decade (Sitrin et al. 1987; Cynamon et al. 1988) . Early signs include absent deep tendon reflexes and loss of position sense and vibration sense in the lower limbs. Nerve conduction studies may demonstrate increased sural nerve conduction latency and decreased action potential amplitude. Visual evoked potentials amd somatosensory evoked potentials may also be abnormal (Kaplan et al. 1988) . More severely affected patients present with dysarthria, tremor, ataxia, proximal muscle weakness and decreased visual acuity. Post mortem there is degeneration of the posterior columns, loss of large unmyelinated axons in peripheral nerves and retinal degeneration. Since the clinical effects of vitamin E deficiency have been recognized, it has become routine to prescribe vitamin E supplements to patients with CF, and ideally the serum vitamin E:total lipids ratio should be measured regularly and supplements adjusted accordingly (Sokol et al. 1984) . When a group of thirty patients in Leeds was supplemented with 50 mg water-miscible vitamin E daily for a period of 18-24 months, there was a progressive rise in mean serum vitamin E levels from 3.61 to 8.30 mg/l (P<O-OOl) over the period of the study and this was accompanied by a small but significant increase in mean haemoglobin from 131.4 to 134-7 gh (P<O.Ol) (Kelleher et al. 1987 ). This effect is most likely to be due to increased erythrocyte survival time once vitamin E deficiency is corrected, since vitamin E deficiency is a recognized cause of haemolytic anaemia in low-birth-weight infants (Oski & Barness, 1967) .
Vitamin E may also be important in controlling the progression of lung disease in CF. A proportion of the lung injury which occurs is thought to be due to the host inflammatory response, in particular the release of free radicals and proteolytic enzymes from neutrophils (Pier, 1985) . The antioxidant properties of a-tocopherol are thought to protect tissues from damage by free radicals and stabilize cell membranes (Bieri et al. 1983 ). However, there are as yet no long-term studies of vitamin E supplementation in CF which have been able to show a beneficial effect on the lung.
VITAMIN A
Retinol is essential for the synthesis of rhodopsin in the retina and for the maintenance of secretory epithelia (Wolf, 1984 ). An early symptom of vitamin A deficiency is night blindness, but this may not be reported by young CF patients unless they are specifically asked. Prolonged vitamin A deficiency leads to keratinizing squamous metaplasia of the conjunctiva, leading to conjunctival xerosis and eventually to xerophthalmia with corneal ulceration (Petersen et al. 1968) . Rarely in infancy, vitamin A deficiency may present with symptoms and signs of raised intracranial pressure (Abernathy, 1976; Eid et al. 1990) . Night blindness was reported in two older children who had been receiving vitamin A supplementation (Fulton et al. 1982) . In a study carried out in Nottingham, a group of thirty-one unselected and twelve selected patients with a median age of 16 years (range 8-46 years) performed dark adaptation tests and were examined by an ophthalmologist (Rayner et al. 1989 ). The latter group were known to have had low serum levels of retinol. Eight patients had abnormally high dark adaptation thresholds, although only four admitted to noticing symptoms. Two of these and one other patient had conjunctival xerosis ). The median serum retinol level in the nine affected patients was only 0.5 (range 0.2-1.4) pmol/l compared with 1.1 (0.5-2.3) pmoV1 in the thirty-four unaffected patients (P=0.002). There was a rapid rise in dark adaptation threshold for values of serum vitamin A below 0.7 pmol/l. Retinol-binding protein levels were also significantly depressed in the affected group but vitamin E levels were similar. Six of the nine affected patients had abnormal liver function and three admitted to poor compliance with vitamin supplementation. Five patients were treated with high doses of water-miscible vitamin A in order to replenish liver stores (StewartTruswell, 1985) and daily supplements of oil-based vitamin A were then adjusted according to serum levels. Dark adaptation thresholds improved rapidly in all except one patient, who had a very low serum level of retinol-binding protein. Conjunctival xerosis was slow to respond to treatment in two brothers until zinc supplements were given in addition to vitamin A. Zn is required for the release of vitamin A and retinol-binding protein from liver stores and acts as a coenzyme for retinol dehydrogenase (EC 1.1.1.105) in the retina (Solomons & Russell, 1980) . Whilst clinical problems directly attributable to vitamin A deficiency are relatively uncommon in CF, the effects of sub-clinical deficiency on the progression of lung disease are not known. Animals made deficient in vitamin A commonly die from respiratory and genito-urinary infections before the eye lesions of xerophthalmia are established. Children in the Third World with mild vitamin A deficiency are at increased risk of respiratory disease and diarrhoea and have an increased mortality rate compared with children who are not vitamin A deficient (Sommer et al. 1984) . Increased bacterial binding to respiratory epithelial cells has been demonstrated in vitamin A deficiency (Chandra, 1988) . A clinical trial of vitamin A supplementation in preterm infants susceptible to bronchopulmonary dysplasia suggested that there was some benefit (Shenai et al. 1987) . Studies need to be performed in CF to assess the long-term effects of vitamin A deficiency on the lung disease. Techniques such as conjunctival impression cytology may prove to be useful as a way of monitoring vitamin A status (Tseng, 1985) .
C O N C L U S I O N S As the prognosis for CF patients has improved, clinical problems due to fat-soluble vitamin deficiencies have been recognized again. The patients most at risk are those with severe malabsorption or poor compliance and those with liver disease. When adolescents and young adults are transferred to the care of adult physicians, less attention may be paid to the nutritional aspects of CF in the face of severe and sometimes life-threatening pulmonary complications. It is, therefore, essential that those of us who care for CF patients during childhood educate them and their families about the importance of taking vitamin supplements and enquire specifically about early symptoms of vitamin deficiency.
